Psoriasis and Glycemic Load: Risks, Mechanisms, and Practical Guidelines

Introductory note: This article was previously published and has been updated according to scientific and informative criteria. The content is for informational purposes only and does not replace the advice of your doctor.

In brief

• Psoriasis is associated, in large-scale observations, with a higher risk of metabolic alterations, including diabetes and insulin resistance.
• The glycemic load of meals (speed and quantity of absorbed sugars) affects glycemia, insulin, and some inflammatory markers; this can be relevant for people with psoriasis.
• Dietary interventions with a low glycemic index/glycemic load show modest but repeatable effects on glycemic control and some inflammatory biomarkers in experimental settings.
• Evidence for the psoriasis-diabetes association is predominantly observational; the causal relationship is not proven and depends on factors such as obesity, medications, and lifestyle.

Abstract: what does science say?

Observational research consistently documents that people with psoriasis have, on average, a higher prevalence and incidence of metabolic syndrome and diabetes compared to the general population. Experimental studies and reviews of dietary interventions show that reducing the glycemic index or glycemic load of meals can improve indicators of glycemic control (e.g., fasting glycemia, HbA1c) and, in some controlled studies, reduce mild markers of systemic inflammation. However, the question of whether glycemic load control directly leads to specific clinical improvements in psoriasis remains open: available data provide biological plausibility (inflammation linked to hyperglycemia and insulin resistance) but not definitive causal proof. Therefore, low-GL/low-GI nutritional management can be considered a possible complementary strategy to reduce associated metabolic factors, but not as a sole treatment for the skin disease. The results should be interpreted in light of known confounders (body weight, physical activity, use of systemic medications or corticosteroids) and methodological differences between observational and experimental studies.

Scientific insights

Epidemiological evidence

Systematic reviews and meta-analyses of observational studies have found an association between psoriasis and an increased risk of type 2 diabetes mellitus: patients with psoriasis, and particularly those with more severe forms, show an increased risk compared to controls. These analyses combine cohorts, case-control studies, and cross-sectional data and suggest a consistent but variable effect depending on the population and the definition of disease severity [1][2]. It is important to emphasize that the evidence is predominantly observational: it measures a correlation that can derive from multiple shared factors (obesity, sedentary lifestyle, smoking, use of certain medications), therefore the association does not in itself imply direct causality. However, the consistency of the results justifies clinical attention and metabolic screening in patients with psoriasis [1][2].

Plausible mechanisms: inflammation and insulin resistance

The biological link between psoriasis and metabolic alterations is based on shared immunometabolic mechanisms. Chronic inflammatory processes, with an increase in pro-inflammatory cytokines such as TNF-α and IL-6, are observed in both psoriasis and insulin resistance, which may explain part of the clinical overlap [3]. Experimental and clinical studies suggest that the presence of skin inflammation can be reflected in systemic alterations of glucose metabolism, and vice versa; furthermore, obesity and inflammatory adipose tissue amplify these circuits. Some recent articles show that insulin resistance can also influence the response to biological treatments for psoriasis, highlighting the importance of the metabolic dimension in the overall management of the disease [3][7].

Role of diet: glycemic index and glycemic load

Glycemic index (GI) and glycemic load (GL) are two indicators used to describe how different foods and meals affect postprandial glycemia. Reviews on the relationship between GI/GL and diabetes risk have concluded that a diet characterized by higher GI/GL is associated with an increased risk of developing type 2 diabetes and other metabolic diseases [4][8]. Randomized controlled interventions have evaluated the effect of low GI/GL diets on glycemia, HbA1c, and inflammatory markers: recent meta-analyses indicate clinically modest but significant improvements in glycemic control and some biomarkers (e.g., slight reduction in CRP) compared to standard diets [6][5]. These results support the plausibility that lowering the glycemic load of a meal reduces hyperglycemic stimuli and the subsequent insulinemic-inflammatory cascade, but specific evidence on the severity of psoriasis remains limited and requires direct studies.

What it means in practice

For those living with psoriasis, current knowledge suggests that intervening on metabolic factors can be useful as part of an integrated approach, without replacing established dermatological therapies. Reducing the glycemic load of meals means preferring carbohydrate sources with slower digestion (whole grains, legumes, low-GI fruits) and combining carbohydrates with fiber, protein, and unsaturated fats to attenuate postprandial glycemic peaks. Low-GI/low-GL dietary interventions, observed in clinical settings, show beneficial effects on glycemic control and can reduce some parameters of systemic inflammation, factors that theoretically can have repercussions on the natural history of psoriasis [6][5].

It is essential, however, to adopt these measures with a personalized approach: the expected effect depends on body weight, physical activity, ongoing drug therapy (for example, corticosteroids can worsen glycemic control), and concomitant clinical conditions. Before significantly changing your diet, it is advisable to consult your doctor or a qualified dietitian to evaluate goals and possible interactions with ongoing therapies. For those interested in trying a low glycemic load strategy, the practical priority is sustainability: small, sustained changes over time (increased fiber, choice of whole carbohydrates, controlled portions) are more effective and safer than drastic and unmonitored interventions.

Key points to remember

• Psoriasis is associated with an increased risk of diabetes and insulin resistance in epidemiological observations; this association is consistent but does not demonstrate direct causality. [1][2]
• Repeated high glycemic loads promote insulinemic responses and can contribute to low-grade systemic inflammation, which is biologically plausible as a modulating factor of the disease. [4][8]
• Low GI/GL diets show modest but useful improvements in glycemic control and some inflammatory biomarkers in randomized controlled studies. [6][5]
• The direct benefit on the clinical severity of psoriasis is not definitively proven: prospective studies and specific trials are needed. [3][7]
• Any dietary modification should be evaluated in a comprehensive and personalized healthcare context, taking into account weight, comorbidities, and pharmacological therapies.

Limitations of the evidence

When reading results on psoriasis and methods to reduce glycemic load, it is crucial to distinguish between types of studies and the strength of conclusions. Much of the information linking psoriasis and diabetes comes from observational studies (cohorts, cross-sectional, case-control), which measure associations; these studies can be influenced by confounding factors (for example, obesity, smoking, socioeconomic status) and the definition of psoriasis severity. Only randomized controlled trials allow the evaluation of causal effects of an intervention (e.g., low-GI/GL diet) on clinical outcomes; such trials show positive effects on glycemic control but rarely have psoriasis severity as an endpoint, making it difficult to draw direct conclusions about the cutaneous therapeutic effect [6][5].

Difference between observational and causal

Observational studies are useful for identifying signals and at-risk populations, but they do not prove that factor A causes effect B. To establish causality, replicated experimental evidence and plausible biological mechanisms are needed. In this specific case, plausibility exists (shared inflammation, metabolic impact of hyperglycemia), however, a solid experimental basis that demonstrates that lowering the glycemic load, in itself, produces a significant and repeatable improvement in psoriasis is still lacking. [1][3][4]

Editorial conclusion

Recent literature confirms that psoriasis is not just a skin disease but is often associated with significant metabolic imbalances. Reducing the glycemic load of meals is a nutritional strategy that has been shown to improve some metabolic and inflammation indicators; this makes it a reasonable option as part of an integrated care pathway, aimed at reducing overall risk factors. However, the evidence does not allow it to be considered a substitute treatment for psoriasis: the decision to intervene at the dietary level should be individualized and evaluated by the clinical team. There remains a high need for clinical studies that directly measure the effects of low-GI/GL strategies on the severity and quality of life of patients with psoriasis.

Editorial note

Article updated according to transparency criteria and source verification. The information reported here is for informational purposes only and does not replace the advice of a healthcare professional. For personalized clinical indications, consult your doctor or specialist.

SCIENTIFIC RESEARCH

1. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the Risk of Diabetes Mellitus: A Systematic Review and Meta‑analysis. JAMA Dermatol. 2013;149(1):84–91. https://doi.org/10.1001/jamadermatol.2013.406
2. The association between psoriasis and diabetes mellitus: A systematic review and meta‑analysis. Diabetes Metab Syndr. 2019. https://doi.org/10.1016/j.dsx.2019.01.009
3. Parraga SP, Feldman SR. Insulin resistance and psoriasis. Br J Dermatol. 2024;191(4):486–487. https://doi.org/10.1093/bjd/ljae199
4. Briggs SJ, et al. Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations. Nutrients. 2019;11(6):1436. https://doi.org/10.3390/nu11061436
5. Neuhouser ML, et al. A Low‑Glycemic Load Diet Reduces Serum C‑Reactive Protein and Modestly Increases Adiponectin in Overweight and Obese Adults. J Nutr. 2011;141:1089–1094. https://doi.org/10.3945/jn.111.149807
6. Chiavaroli L, et al. Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta‑analysis of randomized controlled trials. BMJ. 2021;374:n1651. https://doi.org/10.1136/bmj.n1651
7. Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes. Diabetes Metab Syndr Obes. (DMSO). https://doi.org/10.2147/DMSO.S312420
8. Glycemic index, glycemic load, and chronic disease risk: a meta‑analysis of observational studies. Am J Clin Nutr. 2008;87(3):627–637. https://doi.org/10.1093/ajcn/87.3.627